These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 32755291
1. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release. Yang Z, Zhang N, Ma T, Liu L, Zhao L, Xie H. Drug Deliv; 2020 Dec; 27(1):1156-1164. PubMed ID: 32755291 [Abstract] [Full Text] [Related]
2. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F, Zheng C, Xin J, Chen F, Ling H, Sun L, Webster TJ, Ming X, Liu J. Int J Nanomedicine; 2016 Dec; 11():3875-90. PubMed ID: 27574421 [Abstract] [Full Text] [Related]
3. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. Wang D, Chen W, Li H, Huang G, Zhou Y, Wang Y, Wan W, You B, Liu Y, Zhang X. Int J Pharm; 2020 Jul 30; 585():119456. PubMed ID: 32492507 [Abstract] [Full Text] [Related]
4. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. Ye Z, Zhang Y, Liu Y, Liu Y, Tu J, Shen Y. Int J Nanomedicine; 2021 Jul 30; 16():2443-2459. PubMed ID: 33814909 [Abstract] [Full Text] [Related]
5. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs. Montero N, Pérez E, Benito M, Teijón C, Teijón JM, Olmo R, Blanco MD. Int J Pharm; 2019 Jan 10; 554():337-351. PubMed ID: 30439492 [Abstract] [Full Text] [Related]
6. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery. Huang H, Yang DP, Liu M, Wang X, Zhang Z, Zhou G, Liu W, Cao Y, Zhang WJ, Wang X. Int J Nanomedicine; 2017 Jan 10; 12():2829-2843. PubMed ID: 28435261 [Abstract] [Full Text] [Related]
8. In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres. Zeybek A, Şanlı-Mohamed G, Ak G, Yılmaz H, Şanlıer ŞH. Chem Biol Drug Des; 2014 Jul 10; 84(1):108-15. PubMed ID: 24524300 [Abstract] [Full Text] [Related]
9. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo. Men W, Zhu P, Dong S, Liu W, Zhou K, Bai Y, Liu X, Gong S, Zhang S. Drug Deliv; 2020 Dec 10; 27(1):180-190. PubMed ID: 31924103 [Abstract] [Full Text] [Related]
10. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y. Mol Pharm; 2014 Jun 02; 11(6):1823-34. PubMed ID: 24779677 [Abstract] [Full Text] [Related]
14. Investigation of novel superparamagnetic Ni0.5Zn0.5Fe2O4@albumen nanoparticles for controlled delivery of anticancer drug. Qasim M, Asghar K, Dharmapuri G, Das D. Nanotechnology; 2017 Sep 08; 28(36):365101. PubMed ID: 28675377 [Abstract] [Full Text] [Related]
15. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery. Varshosaz J, Hassanzadeh F, Mardani A, Rostami M. Pharm Dev Technol; 2015 Mar 08; 20(2):183-96. PubMed ID: 24219091 [Abstract] [Full Text] [Related]
16. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system. Gharbavi M, Johari B, Eslami SS, Mousazadeh N, Sharafi A. Cell Biol Int; 2020 Dec 08; 44(12):2485-2498. PubMed ID: 32841441 [Abstract] [Full Text] [Related]
18. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery. Chen T, Xiao Y, Lu W, Liu S, Gan L, Yu J, Huang J. Colloids Surf B Biointerfaces; 2018 Jan 01; 161():606-613. PubMed ID: 29156337 [Abstract] [Full Text] [Related]
20. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H, Shen W, Liu W, Chen L, Zhang P, Xiao C, Chen X. Biomacromolecules; 2018 Nov 12; 19(11):4492-4503. PubMed ID: 30346147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]